You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

moderately differentiated/undifferentiated

Showing 1 - 25 of 1,584
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)

Completed
Has Results
  • Nasopharyngeal Carcinoma
  • Marietta, Georgia
  • +17 more
Jan 17, 2022

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Recruiting
  • Breast Cancer
  • +2 more
    • Bouge, Belgium
      Clinique Saint-Luc Bouge
    Oct 25, 2022

    Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Bourdeaux, France
    • +24 more
    Jun 23, 2023

    Poorly Differentiated Malignant Neuroendocrine Carcinoma, Neuroendocrine Carcinoma, Grade 3, Neuroendocrine Carcinoma, Grade 1

    Completed
    • Poorly Differentiated Malignant Neuroendocrine Carcinoma
    • +4 more
    • Everolimus (Afinitor®)
    • Berlin, Germany
      Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatolog
    Oct 27, 2020

    Stage IV Lung Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

    Terminated
    Has Results
    • Stage IV Lung Cancer
    • Antineoplaston therapy (Atengenal + Astugenal)
    • Houston, Texas
      Burzynski Clinic
    Dec 14, 2020

    Multi-dimensional Fragmentomic Assay for Early Detection of

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Fragmentomic profiles of plasma cfDNA
    • (no location specified)
    Apr 27, 2023

    Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly

    Recruiting
    • Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 23, 2021

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Neuroendocrine Tumors Trial in San Francisco (RAD001, erlotinib)

    Terminated
    Has Results
    • Neuroendocrine Tumors
    • San Francisco, California
      University of California, San Francisco
    Sep 27, 2020

    Cancer Trial in Germany (Avelumab)

    Completed
    • Cancer
    • Halle (Saale), Germany
    • +3 more
    Feb 24, 2022

    Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)

    Recruiting
    • Sarcoma, Soft Tissue
    • Shanghai, Shanghai, China
      Fudan University, Cancer Hospital
    Jul 13, 2020

    Prostate Cancer Trial in San Francisco (Pyruvate (13C), Hyperpolarized 13C,15N2-urea, Magnetic Resonance Spectroscopic Imaging)

    Active, not recruiting
    • Prostate Cancer
    • Pyruvate (13C)
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    May 16, 2022

    Differentiated Thyroid Cancer Patients Treated With Different

    Not yet recruiting
    • Thyroid Cancer
    • (no location specified)
    Nov 15, 2023

    Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

    Active, not recruiting
    • Thyroid Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 8, 2022

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

    Recruiting
    • Pancreatic Neuroendocrine Tumor
    • peptide receptor radionuclide therapy with Y-90-DOTATOC
    • Milano, Italy
    • +1 more
    Sep 30, 2022

    Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

    Not yet recruiting
    • Undifferentiated Pleomorphic Sarcoma
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Nov 1, 2023

    Neuroendocrine Tumors, Pancreatic Tumors Trial in Spain (TH-302 + Sunitinib)

    Completed
    Has Results
    • Neuroendocrine Tumors
    • Pancreatic Neoplasms
    • TH-302 + Sunitinib
    • L'Hospitalet de Llobregat, Barcelona, Spain
    • +9 more
    Jul 9, 2020

    Transient Loss of Consciousness and Suspected Syncope in

    Recruiting
    • Syncope
    • Data collection
    • Durres, Albania
    • +56 more
    Oct 4, 2022

    High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) Trial in San Francisco, Boston, New York (Pembrolizumab, Irinotecan,

    Completed
    Has Results
    • High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
    • San Francisco, California
    • +2 more
    Dec 5, 2022

    Agitation, Schizophrenia, Schizoaffective Disorder Trial (Sublingual film containing dexmedetomidine (BXCL501))

    Not yet recruiting
    • Agitation
    • +4 more
    • Sublingual film containing dexmedetomidine (BXCL501)
    • (no location specified)
    Jul 26, 2023

    18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

    Recruiting
    • Thyroid Cancer
    • Traditional neck dissection approach
    • Anterior neck dissection approach
    • Medellin, Antioquia, Colombia
      Hospital Alma Mater de Antioquia
    Nov 20, 2023